Furthermore, the association between high levels of the IFNγ MCP and favorable outcomes was found in a cross-TCGA analysis and within individual indications, such as sarcoma, breast cancer, or bladder cancer (Fig. 7c). The gene discussed is IFNG; the disease is urinary bladder carcinoma.